Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.840
+0.060 (3.37%)
At close: May 16, 2025, 4:00 PM
1.810
-0.030 (-1.63%)
After-hours: May 16, 2025, 7:34 PM EDT

Phio Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-6.77-7.15-10.83-11.48-13.29-8.79
Upgrade
Depreciation & Amortization
00.040.180.190.190.07
Upgrade
Loss (Gain) From Sale of Assets
-0.01-0.01----
Upgrade
Asset Writedown & Restructuring Costs
--0.13---
Upgrade
Stock-Based Compensation
0.160.150.30.410.480.14
Upgrade
Other Operating Activities
-----0.230.11
Upgrade
Change in Accounts Payable
0.11-0.4-0.120.5-0.45-0.08
Upgrade
Change in Other Net Operating Assets
0.130.27-0.41-1.751.44-0.25
Upgrade
Operating Cash Flow
-6.38-7.11-10.75-12.13-11.86-8.8
Upgrade
Capital Expenditures
-0-0-0.01-0.12-0.05-0.02
Upgrade
Sale of Property, Plant & Equipment
0.010.01----
Upgrade
Investing Cash Flow
0.010.01-0.01-0.12-0.05-0.02
Upgrade
Long-Term Debt Issued
-----0.23
Upgrade
Long-Term Debt Repaid
------0.03
Upgrade
Net Debt Issued (Repaid)
-----0.2
Upgrade
Issuance of Common Stock
13.1847.45-21.7215.94
Upgrade
Repurchase of Common Stock
-0-0.01-0.04-0.03-0-0.02
Upgrade
Financing Cash Flow
13.1747.41-0.0321.7216.13
Upgrade
Net Cash Flow
6.8-3.11-3.34-12.289.817.31
Upgrade
Free Cash Flow
-6.38-7.11-10.75-12.25-11.91-8.82
Upgrade
Free Cash Flow Per Share
-8.87-9.03-46.45-97.00-100.24-207.68
Upgrade
Cash Interest Paid
0.010.010.01--0.01
Upgrade
Levered Free Cash Flow
-4.03-4.54-6.58-7.81-6.71-5.55
Upgrade
Unlevered Free Cash Flow
-4.03-4.54-6.58-7.81-6.71-5.55
Upgrade
Change in Net Working Capital
-0.240.110.371.13-1.110.25
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q